• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, September 8, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Profiling artemisinin’s antimalarial mechanism: Jigang Wang’s research team reveals crucial target proteins

Bioengineer by Bioengineer
September 21, 2023
in Health
Reading Time: 3 mins read
0
This study indicated that ATS could bind to several critical proteins to interfere with the protein synthesis, lipid metabolism, and redox homeostasis of Plasmodium falciparum and exert its antimalarial effects.
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Jigang Wang et al. have made significant progress in unraveling the antimalarial mechanisms of artemisinin (ART) and its derivatives. Their latest research, published in the journal Engineering, sheds light on the crucial target proteins and pathways of ART, providing valuable insights into combating malaria and addressing emerging ART resistance.

This study indicated that ATS could bind to several critical proteins to interfere with the protein synthesis, lipid metabolism, and redox homeostasis of Plasmodium falciparum and exert its antimalarial effects.

Credit: Peng Gao et al.

Jigang Wang et al. have made significant progress in unraveling the antimalarial mechanisms of artemisinin (ART) and its derivatives. Their latest research, published in the journal Engineering, sheds light on the crucial target proteins and pathways of ART, providing valuable insights into combating malaria and addressing emerging ART resistance.

Malaria continues to pose a serious threat to global health, despite the widespread use of ART and its derivatives, which have significantly reduced the global burden of the disease. To address this ongoing challenge, it is crucial to understand the exact antimalarial mechanisms of ART. The research team utilized a combined strategy involving mass spectrometry-coupled cellular thermal shift assay (MS-CETSA) and transcriptomics profiling to identify a group of putative antimalarial targets of ART.

By employing MS-CETSA, the team identified potential antimalarial targets of ART based on the principle that drug binding events affect the thermal stability of the targeting proteins. The results were then combined with transcriptomic analysis to determine the critical antimalarial target proteins and corresponding causal pathways. Subsequent validation experiments on five prospective protein targets revealed that ART may function against malaria parasites by interfering with redox homeostasis, lipid metabolism, and protein synthesis processes.

“These findings provide fresh perspectives on the antimalarial mechanisms of ART and offer crucial insights into several proteins involved in parasite survival that can be targeted to combat malaria,” said Jiaming Wu, the editor of the Engineering. “With signs of emerging ART resistance observed in some regions, understanding the exact mechanisms of ART is of utmost importance.”

Artemisinin and its derivatives are currently the cornerstone drugs of malaria therapy. However, the emergence and spread of ART resistance underscore the need for greater knowledge of its antimalarial mechanism. The identification of critical targets and pathways serves as a stepping stone for the rational optimization of existing artemisinin-based combination therapies (ACTs) and the development of strategies to alleviate ART resistance.

The research not only clarifies the antimalarial mechanism of ART but also establishes potential methodologies for mechanistic studies of other antimalarial drugs. These findings will contribute to the ongoing efforts to combat malaria and improve global health outcomes.

The paper “Profiling the Antimalarial Mechanism of Artemisinin by Identifying Crucial Target Proteins”, authored by Peng Gao, Jianyou Wang, Jiayun Chen, Liwei Gu, Chen Wang, Liting Xu, Yin Kwan Wong, Huimin Zhang, Chengchao Xu, Lingyun Dai, Jigang Wang. Full text of the open access paper: https://doi.org/10.1016/j.eng.2023.06.001. For more information about the Engineering, follow us on Twitter (https://twitter.com/EngineeringJrnl) & Like us on Facebook (https://www.facebook.com/EngineeringPortfolio).

 

About Engineering:

Engineering (ISSN: 2095-8099 IF:12.8) is an international open-access journal that was launched by the Chinese Academy of Engineering (CAE) in 2015. Its aims are to provide a high-level platform where cutting-edge advancements in engineering R&D, current major research outputs, and key achievements can be disseminated and shared; to report progress in engineering science, discuss hot topics, areas of interest, challenges, and prospects in engineering development, and consider human and environmental well-being and ethics in engineering; to encourage engineering breakthroughs and innovations that are of profound economic and social importance, enabling them to reach advanced international standards and to become a new productive force, and thereby changing the world, benefiting humanity, and creating a new future.



Journal

Engineering

DOI

10.1016/j.eng.2023.06.001

Article Title

Profiling the Antimalarial Mechanism of Artemisinin by Identifying Crucial Target Proteins

Article Publication Date

24-Jun-2023

Share12Tweet8Share2ShareShareShare2

Related Posts

TriCAM Study Explores Complementary Medicine in Stem Cell Transplants

September 8, 2025

PRMT1 Protein Mitigates Brain Damage After Ischemia by Inhibiting RIPK1-Driven Cell Death Pathways

September 8, 2025

New C-3-Substituted Oleanolic Acid Benzyl Amide Shows Promise Against Influenza A by Inhibiting PA–PB1 Interaction and Regulating Macrophage Inflammation

September 8, 2025

Just 1 in 7 Online Health Images Demonstrate Correct Blood Pressure Measurement Technique

September 8, 2025

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    151 shares
    Share 60 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • First Confirmed Human Mpox Clade Ib Case China

    56 shares
    Share 22 Tweet 14
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    47 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Research Spotlight: Immune Defense Creates Openings in the Heart

UZH Device Pioneers Search for Light Dark Matter

TriCAM Study Explores Complementary Medicine in Stem Cell Transplants

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.